+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Sarcopenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Sarcopenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
From
From
From
From
From
Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
From
From
BREO Ellipta Drugs Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

BREO Ellipta Drugs Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Montelukast Sodium Market - Product Thumbnail Image

Montelukast Sodium Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Epinephrine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Epinephrine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User - Product Thumbnail Image

Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User

  • Report
  • August 2023
  • 136 Pages
  • North America, Latin America North America, Latin America
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more